Hot Features
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Velan Capital Partners LP | Institution | 2 668 395 | 9,53% | US$ 1,47M | 2026-03-31 |
| Integrated Core Strategies (US) LLC | Institution | 1 624 076 | 5,80% | US$ 895,35k | 2026-02-18 |
| Millennium Management LLC | Institution | 1 617 531 | 5,78% | US$ 891,74k | 2026-03-31 |
| Acorn Bioventures | Institution | 1 411 492 | 5,04% | US$ 778,16k | 2026-03-31 |
| Kingdon Capital Management, L.L.C. | Institution | 1 352 106 | 4,83% | US$ 745,42k | 2026-03-31 |
| Morgan Stanley | Institution | 1 333 420 | 4,76% | US$ 735,11k | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1 172 597 | 4,19% | US$ 646,45k | 2026-03-31 |
| Rock Springs Capital Management LP | Institution | 1 100 726 | 3,93% | US$ 606,83k | 2026-03-31 |
| Abingworth LLP | Institution | 1 066 189 | 3,81% | US$ 587,79k | 2026-03-31 |
| Abingworth Bioventures VII LP | Institution | 1 066 189 | 3,81% | US$ 587,79k | 2026-02-18 |
| Qiming U.S. Healthcare Fund II, L.P. | Institution | 928 964 | 3,32% | US$ 512,14k | 2025-09-30 |
| Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | Institution | 928 964 | 3,32% | US$ 512,14k | 2025-09-30 |
| Acorn Bioventures 2, L.P. | Institution | 862 166 | 3,08% | US$ 475,31k | 2026-01-23 |
| Acorn Bioventures, L.P. | Institution | 624 326 | 2,23% | US$ 344,19k | 2026-01-23 |
| Boothbay Fund Management, LLC | Institution | 582 751 | 2,08% | US$ 321,27k | 2026-03-31 |
| Lion Point Capital, LP | Institution | 465 000 | 1,66% | US$ 256,35k | 2026-03-31 |
| Jacobs Levy Equity Management Inc | Institution | 322 273 | 1,15% | US$ 177,67k | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 317 677 | 1,13% | US$ 175,14k | 2026-03-31 |
| Bank of America Corporation | Institution | 293 259 | 1,05% | US$ 161,67k | 2026-03-31 |
| Soleus Capital Management, L.P. | Institution | 276 312 | 0,99% | US$ 152,33k | 2026-03-31 |
| Avego Management, LLC | Institution | 245 328 | 0,88% | US$ 135,25k | 2025-09-19 |
| Avego Healthcare Capital, L.P. | Institution | 245 328 | 0,88% | US$ 135,25k | 2025-09-19 |
| BlackRock, Inc. | Institution | 242 061 | 0,86% | US$ 133,45k | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 177 500 | 0,63% | US$ 97,86k | 2026-03-31 |
| Sphera Biotech Master Fund L.P. | Institution | 163 211 | 0,58% | US$ 89,98k | 2024-09-30 |
| Knott Partners Management, LLC | Institution | 160 789 | 0,57% | US$ 88,64k | 2026-03-31 |
| Soleus Capital LLC | Institution | 157 400 | 0,56% | US$ 86,77k | 2026-03-31 |
| Soleus Private Equity Fund III LP | Institution | 157 400 | 0,56% | US$ 86,77k | 2026-03-31 |
| Dr. Judith Shizuru | Initiés | 156 901 | 0,56% | US$ 86,50k | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 149 943 | 0,54% | US$ 82,66k | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 140 000 | 0,50% | US$ 77,18k | 2026-03-31 |
| The Quarry LP | Institution | 131 529 | 0,47% | US$ 72,51k | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 128 862 | 0,46% | US$ 71,04k | 2026-03-31 |
| Soleus Capital Master Fund, L.P. | Institution | 118 912 | 0,42% | US$ 65,56k | 2026-03-31 |
| UBS Asset Management AG | Institution | 81 117 | 0,29% | US$ 44,72k | 2026-03-31 |
| Mr. Ronald Martell | Initiés | 74 118 | 0,26% | US$ 40,86k | 2026-03-31 |
| Verdad Advisers, L.P. | Institution | 73 967 | 0,26% | US$ 40,78k | 2026-03-31 |
| Squarepoint OPS LLC | Institution | 64 915 | 0,23% | US$ 35,79k | 2026-03-31 |
| IEQ Capital, LLC | Institution | 51 428 | 0,18% | US$ 28,35k | 2026-03-31 |
| Mr. Thomas Wiggans | Initiés | 46 000 | 0,16% | US$ 25,36k | 2026-03-31 |
| Marshall Wace LLP | Institution | 45 656 | 0,16% | US$ 25,17k | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 44 699 | 0,16% | US$ 24,64k | 2026-03-31 |
| Nine Masts Capital Limited | Institution | 44 165 | 0,16% | US$ 24,35k | 2026-03-31 |
| Osaic Advisory Services, LLC | Institution | 40 850 | 0,15% | US$ 22,52k | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.